Promotions & Moves

Ipsen Appoints R&D EVP and CSO

Lebeaut to lead the transformation of Ipsen’s R&D strategy

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Alexandre Lebeaut has been appointed executive vice president, R&D, and chief scientific officer, Ipsen. Dr. Lebeaut will report to chief executive officer, David Meek, and will serve on the executive leadership team. Dr. Lebeaut joined Ipsen in 2013 as senior vice president, chief development officer, Global Drug Development and was appointed interim head of R&D in December 2016.   Mr. Meek said, “It is my great pleasure to appoint Dr. Lebeaut to lead Ipsen’s R&D organization....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters